Assignee profile:

SpecGx LLC

City:

Webster Groves, Missouri

Country:

United States

Published Applications:

24

Last publication date:

2023-03-16

Patent Grants:

21

Last grant date:

2025-01-28

Top Inventors for applications by SpecGx LLC

These are the the leading inventors for applications assigned to SpecGx LLC:

Recent patent applications by SpecGx LLC

SpecGx LLC based in Webster Groves, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-03-16 ✅ Patent 12,208,094 granted on 2025-01-28
US20230079134A1
Human necessities

Extended release, abuse deterrent dosage forms

#2 | 2023-03-09 ✅ Patent 12,371,423 granted on 2025-07-29
US20230074804A1
Chemistry; metallurgy

PREPARATION OF SUFENTANIL CITRATE AND SUFENTANIL BASE

#3 | 2022-03-17
US20220079938A1
Human necessities

PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF ALPHA, BETA-UNSATURATED KETONE COMPOUNDS

#4 | 2021-11-18 ✅ Patent 11,666,509 granted on 2023-06-06
US20210353502A1
Human necessities

Systems and methods for high humidity curing within tablet coating system

#5 | 2020-11-26 ✅ Patent 11,583,493 granted on 2023-02-21
US20200368148A1
Human necessities

Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides

#6 | 2020-10-29
US20200338068A1
Human necessities

PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDS

#7 | 2020-08-27 ✅ Patent 11,446,293 granted on 2022-09-20
US20200268747A1
Human necessities

Extended release, abuse deterrent dosage forms

#8 | 2020-03-26 ✅ Patent 11,478,426 granted on 2022-10-25
US20200093749A1
Human necessities

Abuse deterrent immediate release capsule dosage forms

#9 | 2020-02-06 ✅ Patent 11,096,887 granted on 2021-08-24
US20200038317A1
Human necessities

Extended release, abuse deterrent pharmaceutical compositions

#10 | 2019-12-19
US20190381033A1
Human necessities

PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDS

#11 | 2019-12-12 ✅ Patent 11,077,024 granted on 2021-08-03
US20190374435A1
Human necessities

Systems and methods for high humidity curing within tablet coating system

#12 | 2019-05-30 ✅ Patent 10,927,068 granted on 2021-02-23
US20190161435A1
Chemistry; metallurgy

Process for preparing acylated amphetamine derivatives

#13 | 2019-05-23 ✅ Patent 10,899,749 granted on 2021-01-26
US20190152961A1
Chemistry; metallurgy

Preparation of sufentanil citrate and sufentanil base

#14 | 2018-12-20 ✅ Patent 11,033,508 granted on 2021-06-15
US20180360764A1
Human necessities

Delayed sustained release pharmaceutical compositions

#15 | 2018-10-18 ✅ Patent 11,517,521 granted on 2022-12-06
US20180296467A1
Human necessities

Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides

#16 | 2018-10-02 ✅ Patent 10,089,678 granted on 2018-10-02
US14192971
Physics

Suspicious order monitoring system and method

#17 | 2018-04-19 ✅ Patent 10,441,508 granted on 2019-10-15
US20180104151A1
Human necessities

Systems and methods for high humidity curing within tablet coating system

#18 | 2017-10-05 ✅ Patent 10,624,888 granted on 2020-04-21
US20170281615A1
Human necessities

Extended release, abuse deterrent dosage forms

#19 | 2017-08-10 ✅ Patent 11,065,246 granted on 2021-07-20
US20170224826A1
Human necessities

Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties

#20 | 2017-05-25 ✅ Patent 10,485,753 granted on 2019-11-26
US20170143699A1
Human necessities

Extended release, abuse deterrent pharmaceutical compositions

#21 | 2016-12-01 ✅ Patent 10,227,335 granted on 2019-03-12
US20160347743A1
Chemistry; metallurgy

Preparation of sufentanil citrate and sufentanil base

#22 | 2016-01-07 ✅ Patent 11,617,712 granted on 2023-04-04
US20160000703A1
Human necessities

Abuse deterrent immediate release formulations comprising non-cellulose polysaccharides

#23 | 2015-12-17 ✅ Patent 11,464,741 granted on 2022-10-11
US20150359743A1
Human necessities

Spray dried compositions having different dissolution profiles and processes for their preparation

#24 | 2013-10-24 ✅ Patent 9,993,422 granted on 2018-06-12
US20130280177A1
Human necessities

Immediate release, abuse deterrent pharmaceutical compositions

Also check out SPECGX LLC's (Webster Groves, United States) applicant profile with 14 patent applications submitted.

AssigneeID:

164599 ⎘